Local and federal funds, special state appropriations, private and philanthropic investments, and innovative value-capture mechanisms must all be considered.
Some Hoosier employers are freezing efforts to recruit H-1B workers because they don’t know if the federal government will apply the $100,000 fee to certain applicants.
Indiana’s growing partnership with Portugal includes imports like rubber, plastics and chemicals, the latter of which is driven largely by pharmaceuticals, according to a Portuguese trade representative.
More than half of the 25-member Indianapolis City-County Council signed a public letter opposing the proposed deal, saying AES Indiana “continues to fall short on service.”
As Elanco Animal Health Inc. settles into its new home in Indianapolis, leaders in Greenfield have turned their attention to the future of the company’s former corporate campus.
The Indiana Office of Utility Consumer Counselor and the Citizen’s Action Coalition both said a settlement plan over electricity rates between AES Indiana, the city and numerous large businesses was not acceptable.
The Indiana Office of Utility Consumer Counselor, which acts on behalf of utility customers, did not join the settlement. Neither did ratepayer advocacy group Citizen’s Action Coalition.
The test—developed in collaboration with Eli Lilly and Co.—does not diagnose Alzheimer’s but is designed to rule out the presence of the disease’s pathology early on, or indicate further diagnostics are needed.
Indianapolis-based Eli Lilly and Co. said the investment will strengthen its manufacturing and supply capabilities to support its growing portfolio of drugs.
The Elanco headquarters is the cornerstone for creating the epicenter of innovation CEO Jeff Simmons envisioned years ago and builds on a series of moves the company has made since it began its headquarters project.
At Wednesday’s ribbon cutting, Elanco CEO Jeff Simmons said the new, three-building campus and developing OneHealth Innovation District “will write the history for the next 70 years of Elanco.”
Shares in Indianapolis-based Eli Lilly and Co. were on the rise Wednesday after President Trump suggested the company would be next up to cut a deal over drug pricing.
The announcements are part of an effort to secure “Most Favored Nation” pricing deals with pharmaceutical manufacturers, an effort to link U.S. drug prices to the lowest cost of drugs paid by the wealthiest countries.
